Zymeworks (ZYME) EBT Margin Growth (1y) (2022 - 2026)
Zymeworks (ZYME) EBT Margin Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - | -184,329.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -184,329.00 |
| Dec 31, 2025 | -159,193.00 |
| Sep 30, 2025 | 11,900.00 |
| Jun 30, 2025 | 19,986.00 |
| Mar 31, 2025 | 23,317.00 |
| Dec 31, 2024 | 5,613.00 |
| Sep 30, 2024 | -1,808.00 |
| Jun 30, 2024 | 51,142.00 |
| Mar 31, 2024 | -25,029.00 |
| Dec 31, 2023 | -21,205.00 |
| Sep 30, 2023 | 165,258.00 |
| Jun 30, 2023 | 48,067.00 |
| Mar 31, 2023 | 372,977.00 |
| Dec 31, 2022 | 60,513.00 |
| Sep 30, 2022 | -45,867.00 |